This study tested a new antiseptic called IRX-101 against the standard povidone-iodine in 155 people receiving eye injections for retinal disease. The goal was to see if IRX-101 reduces pain and corneal damage after the injection. Researchers measured safety and corneal staining …
Phase: PHASE2 • Sponsor: iRenix Medical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC